CONCORD BIOTECH
Back to Income Statement
|
CONCORD BIOTECH Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹1,055 Cr | ₹1,200 Cr | ₹1,017 Cr | ₹853 Cr | ₹713 Cr |
What is the latest Revenue of CONCORD BIOTECH ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹1,055 Cr |
| Mar2025 | ₹1,200 Cr |
| Mar2024 | ₹1,017 Cr |
| Mar2023 | ₹853 Cr |
| Mar2022 | ₹713 Cr |
How is Revenue of CONCORD BIOTECH Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,055 Cr | -12.10 | |
| Mar2025 | ₹1,200 Cr | 18.01 | |
| Mar2024 | ₹1,017 Cr | 19.20 | |
| Mar2023 | ₹853 Cr | 19.67 | |
| Mar2022 | ₹713 Cr | - | |
Compare Revenue of peers of CONCORD BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CONCORD BIOTECH | ₹12,864.2 Cr | -3.1% | -10.6% | -18.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹425,150.0 Cr | 0.8% | -2.1% | 4.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹266,265.0 Cr | 4.9% | 7.9% | 54.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,300.0 Cr | 1.6% | -2.7% | 28.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,351.0 Cr | 2.6% | 14.2% | 3.9% | Stock Analytics | |
| CIPLA | ₹112,474.0 Cr | 2.4% | 3.4% | -12% | Stock Analytics | |
CONCORD BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CONCORD BIOTECH | -3.1% |
-10.6% |
-18.8% |
| SENSEX | 4.5% |
6.1% |
-9.3% |
You may also like the below Video Courses